Access cutting-edge triple-negative breast cancer treatment through this clinical trial at a research site in Mobile. Study-provided care at no cost to qualified participants.
Quick Self-Assessment
See if you qualify for this Mobile location
Access triple-negative breast cancer specialists at no cost
This study follows strict safety protocols and ethical guidelines
All study-related triple-negative breast cancer treatment provided free
Check if you qualify for this triple-negative breast cancer clinical trial in Mobile, AL
No-Cost Study Care
Local to Mobile
Convenient for AL residents
Cutting-Edge Treatment
Access to innovative therapies
Expert Medical Care
Close monitoring by specialists
Possible Compensation*
For time and travel
*Compensation varies by study. Confirm details with coordinator.
Researchers want to know if sacituzumab tirumotecan given alone or with pembrolizumab can treat triple negative breast cancer (TNBC). The main goal of this study is to learn if people treated with sacituzumab tirumotecan alone or with pembrolizumab live longer overall or without the cancer growing or spreading compared to people treated with chemotherapy.
Sponsor: Merck Sharp & Dohme LLC
Yes, this clinical trial (NCT06841354) has an active research site in Mobile, AL that is currently enrolling participants.
Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.
Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.
Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.
If you're searching for triple-negative breast cancer treatment options in Mobile, AL, this clinical trial (NCT06841354) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Mobile research site is actively enrolling participants for this clinical trial. You'll receive care from experienced triple-negative breast cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.
Looking for more options? Browse all triple-negative breast cancer clinical trials near you to find additional studies recruiting in your area.
See all breast cancer clinical trials recruiting in Mobile — not just this study.
Browse Breast Cancer Trials in Mobile →